Ultrasonography Guided Subacromial Sodium Hyaluronate Injection in Rotator Cuff Disease
Evaluating the Efficacy of Ultrasonography Guided Subacromial Sodium Hyaluronate Injection in the Treatment of Rotator Cuff Disease
1 other identifier
interventional
48
1 country
1
Brief Summary
This study will be performed to examine the effect of ultrasound-guided subacromial sodium hyaluronate injection in patients with impingement syndrome without rotator cuff complete tear.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Feb 2012
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2012
CompletedFirst Submitted
Initial submission to the registry
November 16, 2012
CompletedFirst Posted
Study publicly available on registry
November 28, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedDecember 4, 2012
December 1, 2012
10 months
November 16, 2012
December 1, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Change from baseline in pain severity after 3 weeks.
The pain score (100 mm Visual Analogue Score ) is evaluated before the first injection and one week after each injection up to 3rd week.
Up to 3 weeks
Study Arms (2)
Sodium hyaluronate
ACTIVE COMPARATORUltrasound guided injection of sodium hyaluronate
Normal saline
PLACEBO COMPARATORUltrasound guided injection of normal saline
Interventions
Ultrasound guided injection of sodium hyaluronate; Fermathron â„¢, 20 mg/2ml of Sodium Hyaluronate, 3 weekly injections.
Ultrasound guided injection of 0.9% normal sodium hyaluronate line solution, at 2 mL/syringe, 3 weekly injections.
Eligibility Criteria
You may qualify if:
- age \>= 18 years
- subacromial impingement syndrome
- without a complete tear of rotator cuff
- willingness to participate
You may not qualify if:
- had any rheumatic disease, glenohumeral osteoarthritis, full-thickness rotator cuff tears, fractures, diabetes mellitus, infections, or tumors.
- had hypersensitivity to hyaluronate
- had participated in any other study within 6 months
- had received a subacromial injection within 8 weeks
- were pregnant or planned to become pregnant
- were at risk of complications of intra-articular injections such as patients who received anti-coagulant drugs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Rehabilitation, Alzahra Hospital
Isfahan, Isfahan, Iran
Related Publications (4)
Andrews JR. Diagnosis and treatment of chronic painful shoulder: review of nonsurgical interventions. Arthroscopy. 2005 Mar;21(3):333-47. doi: 10.1016/j.arthro.2004.11.003.
PMID: 15756189BACKGROUNDMeloni F, Milia F, Cavazzuti M, Doria C, Lisai P, Profili S, Meloni GB. Clinical evaluation of sodium hyaluronate in the treatment of patients with sopraspinatus tendinosis under echographic guide: experimental study of periarticular injections. Eur J Radiol. 2008 Oct;68(1):170-3. doi: 10.1016/j.ejrad.2007.11.001. Epub 2007 Dec 21.
PMID: 18096343BACKGROUNDKim YS, Park JY, Lee CS, Lee SJ. Does hyaluronate injection work in shoulder disease in early stage? A multicenter, randomized, single blind and open comparative clinical study. J Shoulder Elbow Surg. 2012 Jun;21(6):722-7. doi: 10.1016/j.jse.2011.11.009. Epub 2012 Feb 25.
PMID: 22366365BACKGROUNDChou WY, Ko JY, Wang FS, Huang CC, Wong T, Wang CJ, Chang HE. Effect of sodium hyaluronate treatment on rotator cuff lesions without complete tears: a randomized, double-blind, placebo-controlled study. J Shoulder Elbow Surg. 2010 Jun;19(4):557-63. doi: 10.1016/j.jse.2009.08.006. Epub 2009 Dec 5.
PMID: 19963403BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Farnaz Dehghan, MD
Isfahan University of Medical Sciences
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 16, 2012
First Posted
November 28, 2012
Study Start
February 1, 2012
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
December 4, 2012
Record last verified: 2012-12